181 related articles for article (PubMed ID: 22304007)
1. Ewing sarcoma: biology-based therapeutic perspectives.
Potratz J; Jürgens H; Craft A; Dirksen U
Pediatr Hematol Oncol; 2012 Feb; 29(1):12-27. PubMed ID: 22304007
[TBL] [Abstract][Full Text] [Related]
2. Expression of EWS-ETS fusions in NIH3T3 cells reveals significant differences to Ewing's sarcoma.
Braunreiter CL; Hancock JD; Coffin CM; Boucher KM; Lessnick SL
Cell Cycle; 2006 Dec; 5(23):2753-9. PubMed ID: 17172842
[TBL] [Abstract][Full Text] [Related]
3. Approaching Ewing sarcoma.
Dirksen U; Jürgens H
Future Oncol; 2010 Jul; 6(7):1155-62. PubMed ID: 20624127
[TBL] [Abstract][Full Text] [Related]
4. Blocking the road, stopping the engine or killing the driver? Advances in targeting EWS/FLI-1 fusion in Ewing sarcoma as novel therapy.
Kovar H
Expert Opin Ther Targets; 2014 Nov; 18(11):1315-28. PubMed ID: 25162919
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.
Fukuma M; Okita H; Hata J; Umezawa A
Oncogene; 2003 Jan; 22(1):1-9. PubMed ID: 12527902
[TBL] [Abstract][Full Text] [Related]
6. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes.
Watanabe G; Nishimori H; Irifune H; Sasaki Y; Ishida S; Zembutsu H; Tanaka T; Kawaguchi S; Wada T; Hata J; Kusakabe M; Yoshida K; Nakamura Y; Tokino T
Genes Chromosomes Cancer; 2003 Mar; 36(3):224-32. PubMed ID: 12557222
[TBL] [Abstract][Full Text] [Related]
7. The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex disease.
Kovar H; Amatruda J; Brunet E; Burdach S; Cidre-Aranaz F; de Alava E; Dirksen U; van der Ent W; Grohar P; Grünewald TG; Helman L; Houghton P; Iljin K; Korsching E; Ladanyi M; Lawlor E; Lessnick S; Ludwig J; Meltzer P; Metzler M; Mora J; Moriggl R; Nakamura T; Papamarkou T; Radic Sarikas B; Rédini F; Richter GH; Rossig C; Schadler K; Schäfer BW; Scotlandi K; Sheffield NC; Shelat A; Snaar-Jagalska E; Sorensen P; Stegmaier K; Stewart E; Sweet-Cordero A; Szuhai K; Tirado OM; Tirode F; Toretsky J; Tsafou K; Üren A; Zinovyev A; Delattre O
Oncotarget; 2016 Feb; 7(8):8613-24. PubMed ID: 26802024
[TBL] [Abstract][Full Text] [Related]
8. Primary Hepatic Ewing Sarcoma With EWS-FLI1 RNA Transcript in a Child.
Pochon C; Martelli H; Mussini C; Pariente D; Heymann MF; Corradini N
J Pediatr Hematol Oncol; 2015 Jul; 37(5):411-3. PubMed ID: 25411865
[No Abstract] [Full Text] [Related]
9. Cruel fusion: What a young man's death means for childhood cancer.
Ledford H
Nature; 2017 Mar; 543(7647):608-611. PubMed ID: 28358102
[No Abstract] [Full Text] [Related]
10. Aberrant laminin beta3 isoforms downstream of EWS-ETS fusion genes in Ewing family tumors.
Irifune H; Nishimori H; Watanabe G; Yoshida K; Ikeda T; Matsui C; Morohashi M; Kawaguchi S; Nagoya S; Wada T; Yamashita T; Nakamura Y; Tokino T
Cancer Biol Ther; 2005 Apr; 4(4):449-55. PubMed ID: 15846078
[TBL] [Abstract][Full Text] [Related]
11. PRAS40 is a functionally critical target for EWS repression in Ewing sarcoma.
Huang L; Nakai Y; Kuwahara I; Matsumoto K
Cancer Res; 2012 Mar; 72(5):1260-9. PubMed ID: 22241085
[TBL] [Abstract][Full Text] [Related]
12. STAT3 is activated in a subset of the Ewing sarcoma family of tumours.
Lai R; Navid F; Rodriguez-Galindo C; Liu T; Fuller CE; Ganti R; Dien J; Dalton J; Billups C; Khoury JD
J Pathol; 2006 Apr; 208(5):624-32. PubMed ID: 16463269
[TBL] [Abstract][Full Text] [Related]
13. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
[TBL] [Abstract][Full Text] [Related]
14. Looking downstream of sarcoma-associated chimeric transcription factors: when is a target really a target?
Mercado GE; Barr FG
Cancer Biol Ther; 2005 Apr; 4(4):456-8. PubMed ID: 15908795
[No Abstract] [Full Text] [Related]
15. Primary Ewing sarcoma of the brain: a case report and literature review.
Kazmi SA; Perry A; Pressey JG; Wellons JC; Hammers Y; Palmer CA
Diagn Mol Pathol; 2007 Jun; 16(2):108-11. PubMed ID: 17525681
[TBL] [Abstract][Full Text] [Related]
16. Ewing Sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions.
Jedlicka P
Int J Clin Exp Pathol; 2010 Mar; 3(4):338-47. PubMed ID: 20490326
[TBL] [Abstract][Full Text] [Related]
17. Development of Mithramycin Analogues with Increased Selectivity toward ETS Transcription Factor Expressing Cancers.
Mitra P; Eckenrode JM; Mandal A; Jha AK; Salem SM; Leggas M; Rohr J
J Med Chem; 2018 Sep; 61(17):8001-8016. PubMed ID: 30114371
[TBL] [Abstract][Full Text] [Related]
18. EWS-ETS oncoproteins: the linchpins of Ewing tumors.
Janknecht R
Gene; 2005 Dec; 363():1-14. PubMed ID: 16202544
[TBL] [Abstract][Full Text] [Related]
19. Ewing sarcoma: clinical state-of-the-art.
Potratz J; Dirksen U; Jürgens H; Craft A
Pediatr Hematol Oncol; 2012 Feb; 29(1):1-11. PubMed ID: 22295994
[TBL] [Abstract][Full Text] [Related]
20. Ewing sarcoma with 7;22 translocation: three new cases and clinicopathological characterization.
Shulman SC; Katzenstein H; Bridge J; Bannister LL; Qayed M; Oskouei S; Shehata BM
Fetal Pediatr Pathol; 2012 Dec; 31(6):341-8. PubMed ID: 22432475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
